Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The Russian pharmaceuticals market registered revenues of $21.8 billion in 2023, representing a compound annual growth rate (CAGR) of 3.0% between 2018 and 2023.
Russia captured a share of 5.9% in the European pharmaceuticals market, in 2023.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Russia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
Reasons to Buy
What was the size of the Russia pharmaceuticals market by value in 2023?
What will be the size of the Russia pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Russia pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Russia's pharmaceuticals market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What was the impact of the Russia-Ukraine war on the market?
8 Company Profiles
8.1. Bayer AG
8.2. OTC Pharma International BV
8.3. Binnopharm Group
8.4. Pharmstandard
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Russia pharmaceuticals market value: $ billion, 2018-23
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Russia pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: Bayer AG: Key Facts
Table 5: Bayer AG: Annual Financial Ratios
Table 6: Bayer AG: Key Employees
Table 7: Bayer AG: Key Employees Continued
Table 8: OTC Pharma International BV: Key Facts
Table 9: OTC Pharma International BV: Key Employees
Table 10: Binnopharm Group: Key Facts
Table 11: Binnopharm Group: Key Employees
Table 12: Pharmstandard: Key Facts
Table 13: Pharmstandard: Key Employees
Table 14: Russia Size of Population (million), 2019-23
Table 15: Russia Real GDP (constant 2010 prices, $ billion), 2019-23
Table 16: Russia GDP (current prices, $ billion), 2019-23
Table 17: Russia Inflation, 2019-23
Table 18: Russia Consumer Price Index (absolute), 2019-23
Table 19: Russia Exchange Rate, 2018-23
List of Figures
Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)